Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLIPA: Oral Bacterial Lysate to Prevent Wheeze in Infants After Severe Bronchiolitis
NCT05064631Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Jan 2022
- Primary completion
- Jun 2024
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of OM-85, sponsored by Queen Mary University of London. Started Jan 2022; status: completed.
02
Drugs
OM-85
Beyond the preview
Go deeper on NCT05064631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05064631.